In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.

A new study from the University of Toronto is changing how scientists think about early signs of dementia. While memory loss ...

The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...

Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...

Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...

Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...